AstraZeneca gets marketing permission for cancer drug in India

New Delhi: AstraZeneca Pharma India on Thursday said it has received approval from the Indian drug regulator to market Durvalumab, a cancer treatment medicine, in the country.

The company has received import and market permission for Durvalumab from the Drug Controller General of India (DCGI), AstraZeneca Pharma India said in a statement.

The approval paves the way for the company to launch the product in the country, it added.

Durvalumab is indicated as a treatment option for patients with locally advanced, unresectable non-small cell lung Cancer (NSCLC) and metastatic urothelial carcinoma.

“The import and market permission for Durvalumab for unresectable stage III Non-Small Cell Lung Cancer (NSCLC) and locally advanced or metastatic urothelial carcinoma is a significant milestone for patients who have currently limited treatment options,” AstraZeneca Pharma India Managing Director Gagan Singh said.

In India, around one third of patients with NSCLC are present with stage III disease and the company is happy to bring the first immunotherapy into this setting for patients, he added.

  • Related Posts

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    Women’s Deaths in Kota Hospital: The continuous deaths of women in Kota’s government hospitals have raised serious questions regarding health arrangements. After the Medical College Hospital, an outcry has now…

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    New Delhi: The Indian Council of Medical Research (ICMR) participated in the national programme ‘विज्ञान–Tech’, organised on the occasion of National Technology Day 2026 at BRIC–National Institute of Immunology (NII), New…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

    Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

    Patient dies after oxygen supply stops in ambulance

    Patient dies after oxygen supply stops in ambulance

    IndiaAI, ICMR sign MoU to advance AI in healthcare

    IndiaAI, ICMR sign MoU to advance AI in healthcare

    Illegal drug manufacturing racket busted in Baddi area

    Illegal drug manufacturing racket busted in Baddi area